331 related articles for article (PubMed ID: 25300172)
1. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Marti S; Carbonell Sanchis R; Burls A
Cochrane Database Syst Rev; 2014 Oct; (10):CD008462. PubMed ID: 25300172
[TBL] [Abstract][Full Text] [Related]
2. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R; Burls A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD008462. PubMed ID: 30058070
[TBL] [Abstract][Full Text] [Related]
3. Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010996. PubMed ID: 32352563
[TBL] [Abstract][Full Text] [Related]
4. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2015 Nov; (11):CD010996. PubMed ID: 26590504
[TBL] [Abstract][Full Text] [Related]
5. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008462. PubMed ID: 35849083
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
[TBL] [Abstract][Full Text] [Related]
7. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children: A systematic review.
Bradford NK; Edwards RM; Chan RJ
Int J Nurs Stud; 2016 Jul; 59():51-9. PubMed ID: 27222450
[TBL] [Abstract][Full Text] [Related]
8. Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.
Zhong L; Wang HL; Xu B; Yuan Y; Wang X; Zhang YY; Ji L; Pan ZM; Hu ZS
Crit Care; 2017 Jan; 21(1):5. PubMed ID: 28063456
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.
van den Bosch CH; van Woensel J; van de Wetering MD
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003295. PubMed ID: 34617602
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children.
Brandão LR; Shah N; Shah PS
Cochrane Database Syst Rev; 2014 Mar; (3):CD005982. PubMed ID: 24615288
[TBL] [Abstract][Full Text] [Related]
12. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
Shah PS; Shah N
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005983. PubMed ID: 24569952
[TBL] [Abstract][Full Text] [Related]
13. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah P; Shah V
Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
[TBL] [Abstract][Full Text] [Related]
14. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer.
Arora RS; Roberts R; Eden TO; Pizer B
Cochrane Database Syst Rev; 2010 Dec; (12):CD007785. PubMed ID: 21154387
[TBL] [Abstract][Full Text] [Related]
15. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
Shah PS; Shah N
Cochrane Database Syst Rev; 2007 Oct; (4):CD005983. PubMed ID: 17943871
[TBL] [Abstract][Full Text] [Related]
16. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation for people with cancer and central venous catheters.
Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
[TBL] [Abstract][Full Text] [Related]
18. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah PS; Shah VS
Cochrane Database Syst Rev; 2008 Apr; (2):CD002772. PubMed ID: 18425882
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.
Wang Y; Ivany JN; Perkovic V; Gallagher MP; Woodward M; Jardine MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009631. PubMed ID: 27039404
[TBL] [Abstract][Full Text] [Related]
20. Heparin versus normal saline for patency of arterial lines.
Robertson-Malt S; Malt GN; Farquhar V; Greer W
Cochrane Database Syst Rev; 2014 May; 2014(5):CD007364. PubMed ID: 24825673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
